Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2019 2
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

3 results
Results by year

Citations

1 article found by citation matching

Search results

Filters applied: . Clear all
Page 1
Incidence of Pediatric Cannabis Exposure Among Children and Teenagers Aged 0 to 19 Years Before and After Medical Marijuana Legalization in Massachusetts.
Whitehill JM, Harrington C, Lang CJ, Chary M, Bhutta WA, Burns MM. Whitehill JM, et al. JAMA Netw Open. 2019 Aug 2;2(8):e199456. doi: 10.1001/jamanetworkopen.2019.9456. JAMA Netw Open. 2019. PMID: 31418807 Free PMC article.
Data analysis was performed from November 12, 2018, to July 20, 2019. EXPOSURE: Cannabis products. MAIN OUTCOMES AND MEASURES: Incidence of RPC-reported cannabis exposure cases, both single substance and polysubstance, for the age group of 0 to 19 years, and cannabis pr
Data analysis was performed from November 12, 2018, to July 20, 2019. EXPOSURE: Cannabis products. MAIN OUTCOMES AND MEASURES: Incide …
Unlicensed and off-label use of medicines at a neonatology clinic in Italy.
Dell'Aera M, Gasbarro AR, Padovano M, Laforgia N, Capodiferro D, Solarino B, Quaranta R, Dell'Erba AS. Dell'Aera M, et al. Pharm World Sci. 2007 Aug;29(4):361-7. doi: 10.1007/s11096-006-9081-z. Epub 2007 Mar 10. Pharm World Sci. 2007. PMID: 17351821
OBJECTIVE: Many drugs used for children are not licensed or are used off-label. An increased risk of medication errors and unexpected adverse drug reactions (ADR) associated with off-label and unlicensed drug prescription has been reported. ...CONCLUSI …
OBJECTIVE: Many drugs used for children are not licensed or are used off-label. An increased risk of medication errors and unexpected …